We are live on ! Find out more
ARRY

Array Biopharma Inc
ARRY

Delisted

ARRY was delisted on the 29th of July, 2019.

Back to rankings

128 hedge funds and large institutions have $447M invested in Array Biopharma Inc in 2013 Q2 according to their latest regulatory filings, with 128 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

51% less call options, than puts

Call options by funds: $396K | Put options by funds: $809K

Holders
128
Holders Change
+128
Holders Change %
–
% of All Funds
4.18%
Holding in Top 10
4
Holding in Top 10 Change
+4
Holding in Top 10 Change %
% of All Funds
0.13%
New
128
Increased
–
Reduced
–
Closed
–
Calls
$396K
Puts
$809K
Net Calls
-$413K
Net Calls Change
-$413K

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
SG Americas Securities
76
SG Americas Securities
New York
$344K +$408K +75,819 New
GCP
77
GSA Capital Partners
United Kingdom
$340K +$403K +74,886 New
BA
78
BlackRock Advisors
Delaware
$323K +$383K +71,242 New
UBS AM
79
UBS AM
Illinois
$313K +$371K +68,996 New
NSEDCP
80
NJ State Employees Deferred Compensation Plan
New Jersey
$272K +$323K +60,000 New
PWLP
81
Prio Wealth Limited Partnership
Massachusetts
$272K +$323K +60,000 New
WFM
82
Wilmington Funds Management
Delaware
$251K +$297K +55,233 New
SIP
83
Stoneridge Investment Partners
Pennsylvania
$234K +$277K +51,452 New
Nomura Holdings
84
Nomura Holdings
Japan
$228K +$271K +50,300 New
Westfield Capital Management
85
Westfield Capital Management
Massachusetts
$195K +$231K +43,000 New
BNP Paribas Financial Markets
86
BNP Paribas Financial Markets
France
$190K +$225K +41,854 New
PPCM
87
Pillar Pacific Capital Management
California
$166K +$196K +36,500 New
Public Employees Retirement Association of Colorado
88
Public Employees Retirement Association of Colorado
Colorado
$144K +$170K +31,700 New
RFC
89
Russell Frank Company
Washington
$122K +$144K +26,768 New
U
90
UBS
Switzerland
$120K +$142K +26,464 New
PPA
91
Parametric Portfolio Associates
Washington
$113K +$134K +24,897 New
CA
92
Commerzbank Aktiengesellschaft
Germany
$108K +$128K +23,887 New
KCG
93
Knight Capital Group
$103K +$122K +22,727 New
Royal Bank of Canada
94
Royal Bank of Canada
Ontario, Canada
$97K +$114K +21,254 New
Group One Trading
95
Group One Trading
Illinois
$97K +$115K +21,348 New
BBI
96
Baxter Bros Inc
Connecticut
$95K +$113K +21,000 New
Barclays
97
Barclays
United Kingdom
$93K +$110K +20,534 New
BWP
98
BSW Wealth Partners
Colorado
$91K +$108K +20,000 New
MA
99
MUFG Americas
New York
$90K +$106K +19,800 New
PA
100
Perceptive Advisors
New York
$88K +$104K +19,320 New
2 3
4
5 6

ARRY Hedge Fund Activity: Q2 2013 in Review

128 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in Array Biopharma Inc (ARRY) for Q2 2013, worth a combined $447M.

Buyers outnumbered sellers: 128 funds opened new ARRY positions and 0 closed out — a net gain of 128 holders — while 0 added to existing stakes and 0 trimmed.

  • 128 institutional investors held Array Biopharma Inc (ARRY) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $447M of Array Biopharma Inc stock for Q2 2013.
  • 128 funds opened new Array Biopharma Inc positions in Q2 2013 and 0 closed out, a net change of +128 holders.

Based on aggregated 13F filings for Q2 2013.